Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,034 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Variation of the prevalence of pediatric polypharmacy: A scoping review.
Baker C, Feinstein JA, Ma X, Bolen S, Dawson NV, Golchin N, Horace A, Kleinman LC, Meropol SB, Pestana Knight EM, Winterstein AG, Bakaki PM. Baker C, et al. Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):275-287. doi: 10.1002/pds.4719. Epub 2019 Feb 6. Pharmacoepidemiol Drug Saf. 2019. PMID: 30724414 Free PMC article. Review.
Plasma glycomics predict cardiovascular disease in patients with ART-controlled HIV infections.
Oswald DM, Sim ES, Baker C, Farhan O, Debanne SM, Morris NJ, Rodriguez BG, Jones MB, Cobb BA. Oswald DM, et al. Among authors: baker c. FASEB J. 2019 Feb;33(2):1852-1859. doi: 10.1096/fj.201800923R. Epub 2018 Sep 5. FASEB J. 2019. PMID: 30183373 Free PMC article.
Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal the untapped prognostic potential of the plasma glycome in human disease.-Oswald, D. M., Sim, E. S., Baker, C., Farhan, O., D …
Our findings constitute the discovery of novel glycan biomarkers that could classify patients with HIV with elevated risk for CVD and reveal …
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Considerations for paediatric patients.
Foley P, Mahar PD, Smith SD, Gupta M, Manuelpillai N, Orchard D, Wong LC, Su JC, James A, Fischer G, Marshman G, Rawlin M, Turner M, King E, Kennedy R, Baker C. Foley P, et al. Among authors: baker c. Australas J Dermatol. 2024 May 13. doi: 10.1111/ajd.14303. Online ahead of print. Australas J Dermatol. 2024. PMID: 38741474
4,034 results